IPA logo

ImmunoPrecise Antibodies (IPA) Return On Equity

Annual ROE

-59.95%
-20.20%-50.82%

April 30, 2024

Summary

Performance

1-Year Change

-50.82%

3-Year Change

-205.4%

5-Year Change

-20.92%

15-Year Change

+84.64%

IPA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.19%
IPA annual return on equity is higher than 37.19% of companies in Healthcare sector

High & Low

All-time High

44.19%
IPA annual return on equity is currently -235.66% below its historical high of 44.19%

3-Year Low

-59.95%
IPA annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
IPA previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
IPA next annual earnings announcement has not yet been scheduled

OtherIPAprofitabilitymetrics:

Annual Revenue

$18.16 M
IPA annual revenue is $18.16 million

Annual Net Income

-$20.12 M
IPA annual net profit is -$20.12 million

Annual EPS

-$0.78
IPA annual earnings per share is -$0.78

Annual ROA

-39.90%
IPA annual return on assets is -39.90%

Quarterly ROE

-68.99%
-7.50%-12.20%

October 31, 2024

Summary

Performance

3-Month Change

-12.2%

1-Year Change

-12.2%

3-Year Change

-12.2%

5-Year Change

-12.2%

IPA Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.42%
IPA quarterly return on equity is higher than 33.42% of companies in Healthcare sector

High & Low

All-time High

348.84%
IPA quarterly return on equity is currently -119.78% below its historical high of 348.84%

3-Year Low

-68.99%
IPA quarterly return on equity is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
IPA previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
IPA next earnings announcement is scheduled for Mar 14, 2025

OtherIPAprofitabilitymetrics:

Quarterly Revenue

$4.49 M
IPA quarterly revenue is $4.49 million

Quarterly Net Income

-$1.87 M
IPA quarterly net profit is -$1.87 million

Quarterly EPS

-$0.07
IPA quarterly earnings per share is -$0.07

Quarterly ROA

-41.65%
IPA quarterly return on assets is -41.65%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

-59.95%
IPA annual return on equity is -59.95%

Annual Net Income

-$20.12 M
IPA annual net profit is -$20.12 million

Annual Shareholders Equity

$24.82 M
IPA annual stockholders equity is $24.82 million

IPA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.8%-12.2%
3 y3 years-205.4%-12.2%
5 y5 years-20.9%-12.2%

IPA ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-205.4%at low-172.7%at low
5 y5-year-205.4%at low-411.0%at low
alltimeall time-235.7%+95.6%-119.8%+94.0%

ImmunoPrecise Antibodies ROE History

DateAnnualQuarterly
Oct 2024
-
-68.99%(+12.2%)
Jul 2024
-
-61.49%(+13.4%)
Apr 2024
-59.95%(+50.8%)
-54.24%(+114.4%)
Jan 2024
-
-25.30%(-7.7%)
Oct 2023
-
-27.41%(-19.6%)
Jul 2023
-
-34.10%(-17.6%)
Apr 2023
-39.75%(+56.0%)
-41.37%(-1.5%)
Jan 2023
-
-41.98%(+0.4%)
Oct 2022
-
-41.81%(+8.1%)
Jul 2022
-
-38.66%(+32.3%)
Apr 2022
-25.48%(+29.8%)
-29.23%(-16.6%)
Jan 2022
-
-35.03%(+8.9%)
Oct 2021
-
-32.18%(+24.4%)
Jul 2021
-
-25.87%(+8.4%)
Apr 2021
-19.63%(-35.9%)
-23.86%(+66.0%)
Jan 2021
-
-14.37%(+6.4%)
Oct 2020
-
-13.50%(-38.0%)
Jul 2020
-
-21.77%(-31.7%)
Apr 2020
-30.62%(-38.2%)
-31.87%(-32.5%)
Jan 2020
-
-47.24%(+0.6%)
Oct 2019
-
-46.96%(-4.2%)
Jul 2019
-
-49.00%(+8.1%)
Apr 2019
-49.58%(-25.6%)
-45.32%(+14.9%)
Jan 2019
-
-39.43%(-13.0%)
Oct 2018
-
-45.32%(-19.5%)
Jul 2018
-
-56.31%(-15.0%)
Apr 2018
-66.67%(-82.9%)
-66.22%(-3.0%)
Jan 2018
-
-68.24%(-61.9%)
Oct 2017
-
-178.91%(-47.1%)
Jul 2017
-
-338.03%(-19.3%)
Apr 2017
-390.21%(-2804.2%)
-418.90%(-34.4%)
Jan 2017
-
-638.46%(-1226.4%)
Sep 2016
-
56.68%(+129.1%)
Jun 2016
-
24.74%(+48.6%)
Mar 2016
-
16.65%(+21.0%)
Dec 2015
14.43%(-54.0%)
-
Dec 2015
-
13.76%(+234.8%)
Sep 2015
-
4.11%(-76.9%)
Jun 2015
-
17.77%(-13.8%)
Mar 2015
-
20.61%(-36.6%)
Dec 2014
31.40%(-170.5%)
-
Dec 2014
-
32.53%(-37.4%)
Sep 2014
-
51.95%(-191.7%)
Jun 2014
-
-56.67%(+33.8%)
Mar 2014
-
-42.35%(+14.3%)
Dec 2013
-44.52%(-200.7%)
-
Dec 2013
-
-37.06%(+55.4%)
Sep 2013
-
-23.85%(-145.8%)
Jun 2013
-
52.09%(-2.0%)
Mar 2013
-
53.14%(-10.1%)
Dec 2012
44.19%(-103.2%)
-
Dec 2012
-
59.11%(-44.8%)
Sep 2012
-
107.00%(-36.9%)
Jun 2012
-
169.53%(-51.4%)
Mar 2012
-
348.84%(-130.1%)
Dec 2011
-1361.75%(+604.5%)
-
Dec 2011
-
-1159.93%(+137.3%)
Sep 2011
-
-488.87%(+95.7%)
Jun 2011
-
-249.76%(+50.9%)
Mar 2011
-
-165.50%(+31.5%)
Dec 2010
-193.29%
-
Dec 2010
-
-125.88%(+590.5%)
Sep 2010
-
-18.23%(+3.3%)
Jun 2010
-
-17.64%(+2.8%)
DateAnnualQuarterly
Mar 2010
-
-17.16%(+3.6%)
Dec 2009
-16.38%(+95.5%)
-
Dec 2009
-
-16.56%(+187.5%)
Sep 2009
-
-5.76%(+2.7%)
Jun 2009
-
-5.61%(-3.4%)
Mar 2009
-
-5.81%(-26.5%)
Dec 2008
-8.38%(-42.0%)
-
Dec 2008
-
-7.90%(+11.7%)
Sep 2008
-
-7.07%(-7.0%)
Jun 2008
-
-7.60%(-54.4%)
Mar 2008
-
-16.67%(+16.2%)
Dec 2007
-14.46%(+62.3%)
-
Dec 2007
-
-14.34%(+20.8%)
Sep 2007
-
-11.87%(-2.9%)
Jun 2007
-
-12.22%(+71.4%)
Mar 2007
-
-7.13%(-13.4%)
Dec 2006
-8.91%(-322.8%)
-
Dec 2006
-
-8.23%(-296.9%)
Sep 2006
-
4.18%(-3583.3%)
Jun 2006
-
-0.12%(-102.4%)
Mar 2006
-
5.05%(-51.7%)
Dec 2005
4.00%(-163.7%)
-
Dec 2005
-
10.46%(-291.2%)
Sep 2005
-
-5.47%(-707.8%)
Jun 2005
-
0.90%(-33.8%)
Mar 2005
-
1.36%(-117.9%)
Dec 2004
-6.28%(-87.4%)
-
Dec 2004
-
-7.58%(-74.7%)
Sep 2004
-
-30.00%(-16.6%)
Jun 2004
-
-35.98%(-17.2%)
Mar 2004
-
-43.47%(-19.1%)
Dec 2003
-49.81%(+35.2%)
-
Dec 2003
-
-53.73%(+105.3%)
Sep 2003
-
-26.17%(-9.4%)
Jun 2003
-
-28.88%(-5.0%)
Mar 2003
-
-30.39%(-5.2%)
Dec 2002
-36.83%(-26.4%)
-
Dec 2002
-
-32.06%(+65.6%)
Sep 2002
-
-19.36%(-27.9%)
Jun 2002
-
-26.86%(-38.1%)
Mar 2002
-
-43.39%(-15.8%)
Dec 2001
-50.04%(+23.8%)
-
Dec 2001
-
-51.54%(-12.9%)
Sep 2001
-
-59.17%(+7.1%)
Jun 2001
-
-55.25%(+18.1%)
Mar 2001
-
-46.79%(+15.4%)
Dec 2000
-40.43%(-68.2%)
-
Dec 2000
-
-40.56%(-82.0%)
Sep 2000
-
-225.38%(+102.2%)
Jun 2000
-
-111.44%(+19.5%)
Mar 2000
-
-93.24%(+22.0%)
Dec 1999
-127.05%(+129.0%)
-
Dec 1999
-
-76.44%(+6.6%)
Sep 1999
-
-71.69%(-5.2%)
Jun 1999
-
-75.65%(-2.7%)
Mar 1999
-
-77.74%(-0.3%)
Dec 1998
-55.47%(+133.4%)
-
Dec 1998
-
-78.00%(+183.0%)
Sep 1998
-
-27.56%(-3.6%)
Jun 1998
-
-28.59%(-4.0%)
Mar 1998
-
-29.77%(+9.4%)
Dec 1997
-23.77%(+19.1%)
-
Dec 1997
-
-27.20%
Dec 1996
-19.95%
-

FAQ

  • What is ImmunoPrecise Antibodies annual return on equity?
  • What is the all time high annual ROE for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies annual ROE year-on-year change?
  • What is ImmunoPrecise Antibodies quarterly return on equity?
  • What is the all time high quarterly ROE for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies quarterly ROE year-on-year change?

What is ImmunoPrecise Antibodies annual return on equity?

The current annual ROE of IPA is -59.95%

What is the all time high annual ROE for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high annual return on equity is 44.19%

What is ImmunoPrecise Antibodies annual ROE year-on-year change?

Over the past year, IPA annual return on equity has changed by -20.20% (-50.82%)

What is ImmunoPrecise Antibodies quarterly return on equity?

The current quarterly ROE of IPA is -68.99%

What is the all time high quarterly ROE for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high quarterly return on equity is 348.84%

What is ImmunoPrecise Antibodies quarterly ROE year-on-year change?

Over the past year, IPA quarterly return on equity has changed by -7.50% (-12.20%)